<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03537534</url>
  </required_header>
  <id_info>
    <org_study_id>C.2018.055d</org_study_id>
    <nct_id>NCT03537534</nct_id>
  </id_info>
  <brief_title>Intraurethral Lidocaine After Endourology Procedures</brief_title>
  <official_title>Intraurethral Lidocaine After Endourology Procedure to Improve Dysuria in Anesthetized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Antonio Uniformed Services Health Education Consortium</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>San Antonio Uniformed Services Health Education Consortium</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many urological conditions are diagnosed and treated with the use of endourology procedures.
      Unfortunately, dysuria is a common patient complaint following these procedures.
      Intraurethral lidocaine instillation is regularly used prior to office-based endourology
      procedures to alleviate dysuria, as well as, discomfort during the procedure.. Studies have
      confirmed that office-based procedures using intraurethral lidocaine have resulted in less
      patient reported dysuria. Many endourology procedures are done under general anesthesia such
      as urinary stone treatments or resection of bladder tumors. There is a paucity of data
      regarding the use of intraurethral lidocaine at the conclusion of these procedures evaluating
      patient reported dysuria. We have designed a prospective, randomized, placebo controlled
      trial to evaluate the role of intraurethral lidocaine instillation following endourology
      procedures in the anesthetized patient.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective patient symptom score</measure>
    <time_frame>1 day (immediately before and after procedure)</time_frame>
    <description>questionnaire scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient complications</measure>
    <time_frame>within 30 days</time_frame>
    <description>Unplanned patient returns to clinic or ED, UTIs, admissions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Dysuria</condition>
  <arm_group>
    <arm_group_label>Experiment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine jelly (2%) 5mL x 1 dose only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Surgilube 5mL x 1 dose only</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Jet Injector</intervention_name>
    <description>Applying Lidocaine following endourologic procedure</description>
    <arm_group_label>Experiment</arm_group_label>
    <other_name>Urojet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Applying surgilube following endourologic procedure</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Surgilube</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Adult patients, age 18 and older scheduled to undergo endourologic
        procedure to include ureteroscopy, rigid diagnostic cystoscopy, bladder biopsy, laser
        lithotripsy, cystolithalopaxy, and transurethral resection of bladder tumor in the
        operating room under general anesthesia.

        Exclusion Criteria: active urinary tract infection, current dysuria symptoms, pregnant
        females, urethral stricture disease, indwelling foley catheter, and history of pelvic
        radiation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Allam, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Antonio Uniformed Services Health Education Consortium</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christopher L Allam, DO</last_name>
    <phone>210-916-6604</phone>
    <email>christopher.l.allam.mil@mail.mil</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Felicia Balzano, MD</last_name>
    <phone>210-916-0716</phone>
    <email>felicia.l.balzano.mil@mail.mil</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BAMC</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Allam, DO</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>May 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Antonio Uniformed Services Health Education Consortium</investigator_affiliation>
    <investigator_full_name>Christopher Allam</investigator_full_name>
    <investigator_title>Director of Endourology and Laparoscopy</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dysuria</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

